NASDAQ : KYMR

Kymera Therapeutics, Inc.

$114.12 USD

$2.04 (1.82%)

Volume
411.01K
Average Volume
794.36K
Market Capitalization
$9.39B
P/E Ratio
-31.88
Dividend Yield
0.00%
Price Target
$129.00
Year High
$130.05
Year Low
$36.65
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$10.81

CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE

0.06%

Investors Holding

10

change: -253 | last: 263

Increased Positions

3

change: -138 | last: 141

Reduced Positions

3

change: -70 | last: 73

New Positions

0

change: -45 | last: 45

Sold Positions

248

change: 205 | last: 43

Total Calls

-

Total Puts

-

Put-Call Ratio

0.00

change: -105.022 | last: 1.0502

Total Invested

6.94M

KYMR Enterprise Value History

Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $77.81 84.39M $6.57B $357.01M $82.25M $6.29B
2024-12-31 $40.23 75.04M $3.02B $120.26M $87.76M $2.99B
2023-12-31 $25.46 58.37M $1.49B $109.97M $84.67M $1.46B
2022-12-31 $24.96 53.93M $1.35B $68.4M $17.34M $1.3B
2021-12-31 $63.49 47.99M $3.05B $47.98M $17.96M $3.02B
2020-12-31 $62.00 44.56M $2.76B $31M $17.99M $2.75B
2019-12-31 $33.26 44.53M $1.48B $76.02M $21.19M $1.43B
2018-12-31 $33.26 44.53M $1.48B $41.26M $695K $1.44B
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-03-31 $83.29 97.53M $8.12B $144.09M $80.47M $8.06B
2025-12-31 $77.81 84.39M $6.57B $357.01M $82.25M $6.29B
2025-09-30 $56.60 87.3M $4.94B $112.95M $84M $4.91B
2025-06-30 $43.64 80.45M $3.51B $335.82M $85.71M $3.26B
2025-03-31 $27.37 80.15M $2.19B $89.97M $86.33M $2.19B
2024-12-31 $40.23 79.99M $3.22B $120.26M $87.76M $3.19B
2024-09-30 $47.33 76.13M $3.6B $110.72M $88.23M $3.58B
2024-06-30 $30.95 73.06M $2.26B $67.61M $88.18M $2.28B
2024-03-31 $39.42 70.77M $2.79B $93.51M $87.02M $2.78B
2023-12-31 $25.46 58.52M $1.49B $109.97M $84.67M $1.46B
2023-09-30 $13.90 58.42M $812.06M $81.05M $80.84M $811.86M
2023-06-30 $22.99 58.33M $1.34B $52.39M $75.06M $1.36B